Napredna pretraga

Pregled bibliografske jedinice broj: 290186

Proteomics in antitumor research


Fontana, Simona; De Leo Giacomo; Sedić, Mirela; Kraljević Pavelić, Sandra; Alessandro, Riccardo
Proteomics in antitumor research // Drug Discovery Today: Technologies, 3 (2006), 4; 441-449 (recenziran, članak, stručni)


Naslov
Proteomics in antitumor research

Autori
Fontana, Simona ; De Leo Giacomo ; Sedić, Mirela ; Kraljević Pavelić, Sandra ; Alessandro, Riccardo

Izvornik
Drug Discovery Today: Technologies (1740-6749) 3 (2006), 4; 441-449

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni

Ključne riječi
Proteomika; tumori; proteinski čipovi; 2DE; masena spektrometrija
(Proteomics; cancer; protein arrays; 2-DE; masena spektrometrija)

Sažetak
Proteins are the molecular players of fine-tuned regulatory pathways that underlie the behavior of any cell type. Derangement of this wide protein circuitry has a profound effect on cell life and ultimately contributes to the development of diseases such as cancer. New proteomic technologies are rapidly evolving to define and characterize the nodes of this altered protein network, both inside and outside cancer cells. Hopefully, these technologies will become user-friendly laboratory tools to improve cancer management from early detection to the development of rational and patient-tailored therapeutic strategies.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti

Napomena
Rad je financiran i iz sredstava s projekta Ministarstva znanosti, obrazovanja i športa "Jezgre-Test" (14M09800 ; voditelj projekta prof. dr. sci. Krešimir Pavelić)



POVEZANOST RADA


Projekt / tema
098-0982464-2393 - Molekularna obilježja miofibroblasta Dupuytrenove bolesti (Krešimir Pavelić, )

Ustanove
Institut "Ruđer Bošković", Zagreb

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus